INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
FS

Forte Steve

EVP, CHIEF FINANCIAL OFFICERCIK 0001815428

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
56.8K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Repare Therapeutics Inc.EVP, CHIEF FINANCIAL OFFICER · Jan 28, 2026
9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D
—
200.0K sh
Jan 28, 2026
Jan 28, 2026
traded Jan 28, 2026
+0d
SEC FORM 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
85.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
500.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
325.8K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence